 |
|
HPV 16 E7:86-93 peptide vaccine
A synthetic peptide vaccine consisting of amino acids 86 through 93 (TLGIVCPI) of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7:86-93 peptide, which binds to HLA-A* 0201 molecule, may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for HPV-16 E7. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | E7(86-93) lipopeptide
HPV 16E7 86-93 Lipopeptide Vaccine
HPV-16E7 (86-93) | | | | Abbreviation: | | E7(86-93) | | |
| Previous: | HLA-A*2404-restricted RNF43-TOMM34-VEGFR1-VEGFR2 multipeptide vaccine, HLA-A1, A2, B35-restricted survivin peptides/Montanide ISA-51 vaccine, HLA-A2, A3-restricted FGF-5 peptides/Montanide ISA-51 vaccine, Hodgkin's antigens-GM-CSF-expressing cell vaccine, HPPH | | Next: | HPV DNA plasmids therapeutic vaccine VGX-3100, HPV L1 VLP vaccine V504, Hsp27 antisense oligonucleotide OGX-427, Hsp90 antagonist KW-2478, Hsp90 inhibitor AUY922 |
|
|
